Testing effectiveness (Phase 2)Study completedNCT01191996
What this trial is testing
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis
Who this might be right for
Secondary Progressive Multiple SclerosisPrimary Progressive Multiple Sclerosis
Innate Immunotherapeutics 34